trial · primary record
Kylo-11 or matched placebo
Lipoprotein Disorder
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 204 |
| Primary completion | 2028-08-31 |
| Primary endpoint | Percent change from baseline in time-averaged Lp(a) over Weeks 8~26 |
| Registry ID | NCT07327840 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:35.336Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07327840
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.